173 related articles for article (PubMed ID: 18374554)
1. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency.
Song X; Zhao Y; Hou S; Xu F; Zhao R; He J; Cai Z; Li Y; Chen Q
Eur J Pharm Biopharm; 2008 Jun; 69(2):445-53. PubMed ID: 18374554
[TBL] [Abstract][Full Text] [Related]
2. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
Song X; Zhao Y; Wu W; Bi Y; Cai Z; Chen Q; Li Y; Hou S
Int J Pharm; 2008 Feb; 350(1-2):320-9. PubMed ID: 17913411
[TBL] [Abstract][Full Text] [Related]
3. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
5. Development and physicochemical characterization of copper complexes-loaded PLGA nanoparticles.
Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Chuburu F
Int J Pharm; 2009 Sep; 379(2):226-34. PubMed ID: 19428198
[TBL] [Abstract][Full Text] [Related]
6. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
[TBL] [Abstract][Full Text] [Related]
7. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
Govender T; Stolnik S; Garnett MC; Illum L; Davis SS
J Control Release; 1999 Feb; 57(2):171-85. PubMed ID: 9971898
[TBL] [Abstract][Full Text] [Related]
9. PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release.
Halayqa M; Domańska U
Int J Mol Sci; 2014 Dec; 15(12):23909-23. PubMed ID: 25535080
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
Budhian A; Siegel SJ; Winey KI
Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
13. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
Zhou YZ; Alany RG; Chuang V; Wen J
Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
16. [VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma].
He YJ; Lin TT; Zhu LM; Luo H; Chang J; Zhang H; Zhang HM
Zhonghua Yan Ke Za Zhi; 2010 Sep; 46(9):795-801. PubMed ID: 21092558
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial efficacy of poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped cinnamon bark extract against Listeria monocytogenes and Salmonella typhimurium.
Hill LE; Taylor TM; Gomes C
J Food Sci; 2013 Apr; 78(4):N626-32. PubMed ID: 23464835
[TBL] [Abstract][Full Text] [Related]
18. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
Okassa LN; Marchais H; Douziech-Eyrolles L; Hervé K; Cohen-Jonathan S; Munnier E; Soucé M; Linassier C; Dubois P; Chourpa I
Eur J Pharm Biopharm; 2007 Aug; 67(1):31-8. PubMed ID: 17289360
[TBL] [Abstract][Full Text] [Related]
19. Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma.
Song XR; Zheng Y; He G; Yang L; Luo YF; He ZY; Li SZ; Li JM; Yu S; Luo X; Hou SX; Wei YQ
J Pharm Sci; 2010 Dec; 99(12):4874-9. PubMed ID: 20821385
[TBL] [Abstract][Full Text] [Related]
20. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles.
Song XR; Cai Z; Zheng Y; He G; Cui FY; Gong DQ; Hou SX; Xiong SJ; Lei XJ; Wei YQ
Eur J Pharm Sci; 2009 Jun; 37(3-4):300-5. PubMed ID: 19491019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
